Indication
Lymphocyte Disorder T
1 clinical trial
1 product
Clinical trial
Investigating the Immunomodulatory Effects of Esmolol in Sepsis Management and Its Impact on Patient OutcomesStatus: Completed, Estimated PCD: 2023-12-31
Product
esmolol1 clinical trial
1 product